<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Marburg_Human_Practice_Talk_of_Peter_Hermentin"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Marburg/Human_Practice/Talk_of_Peter_Hermentin">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Marburg/Human_Practice/Talk_of_Peter_Hermentin&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Marburg/Human_Practice/Talk_of_Peter_Hermentin&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Marburg/Human_Practice/Talk_of_Peter_Hermentin&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Marburg/Human_Practice/Talk_of_Peter_Hermentin" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Marburg/Human Practice/Talk of Peter Hermentin</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2013.igem.org</H3><DIV id="header"><DIV id="header-focus"><DIV id="header-nav-box"><DIV id="header-navigation"><UL class="level1"><LI><A href="https://2013.igem.org/Team:Marburg">Home</A></LI><LI><A class="fly" href="https://2013.igem.org/Team:Marburg/Project">Project</A></LI><LI><A class="fly" href="https://2013.igem.org/Team:Marburg/Project">PHAECTORY</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Project:Challenge">Challenge</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Project:Ptricornutum"><I>P. tricornutum</I></A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Project:Milestones">Milestones</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Results">Results</A></LI></UL><LI><A href="https://2013.igem.org/Team:Marburg/Project:RFP">Improve a brick</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Project:lightcontrol">Light control</A></LI><LI><A class="fly" href="#url">Notebook</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Notebook:Ptricornutum"><I>P. tricornutum</I></A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Notebook:March">March</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Notebook:April">April</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Notebook:Mai">May</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Notebook:June">June</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Notebook:July">July</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Notebook:August">August</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Notebook:September">September</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Notebook:October">October</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Notebook:Primer_list">Supplementary</A></LI><LI><A class="fly" href="https://2013.igem.org/Team:Marburg/Team">Team</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Team">Our Team</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Team:Members">Members</A></LI><LI><A href="https://igem.org/Team.cgi?year=2013&amp;team_name=Marburg" target="_blank">Official Profile</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Team:Philipps_University_Marburg">Philipps-University</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Team:Contact">Contact</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Parts">Parts</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Safety">Safety</A></LI><LI><A class="fly" href="https://2013.igem.org/Team:Marburg/Human_Practice">Human Practice</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice">Overview</A></LI><LI><A class="fly" href="#">Collaborations</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice/Collaboration:Isreal">Israel</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice/Collaboration:Norwich">Norwich</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice/Conferences:BioTech2020plus">Biotechnology 2020+</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice/Conferences:MissionsSynmikro">Missions Synmikro</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice/Conferences:SYNMIKRO">SYNMIKRO</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice:DayofSynthBiology">SynBio Day</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice:Debate">Debate</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice:Hessentag">Hessentag</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice:Students">Lab Day</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice/Talk_of_Peter_Hermentin">Peter Hermentin</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice/Bioethics">Bioethics</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Sponsors">Sponsors</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Attributions">Attributions</A></LI></DIV></DIV></DIV></DIV><DIV id="mr-bg-wrapper"><DIV id="mr-main-wrapper"><H1 class="content-title">	

Talk of Peter Hermentin  </H1><DIV id="mr-sidebar"><UL id="mr-sidebar-list"><LI><B>Collaborations</B></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice/Collaboration:Isreal">Israel</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice/Collaboration:Norwich">Norwich</A></LI></UL><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice/Conferences:BioTech2020plus">BioTech 2020+</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice/Conferences:MissionsSynmikro">Missions</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice/Conferences:SYNMIKRO">SYNMIKRO</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice:DayofSynthBiology">SynBio Day</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice:Debate">Debate</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice:Hessentag">Hessentag</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice:Students">Lab Day</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice/Talk_of_Peter_Hermentin">Peter Hermentin</A></LI><LI><A href="https://2013.igem.org/Team:Marburg/Human_Practice/Bioethics">Bioethics</A></LI></DIV><DIV id="mr-wrapper">On the 23th of July, the iGEM Marburg got the opportunity to attend a lecture of Dr. Peter Hermentin, a former inventor at Behringwerke AG in Marburg. In his short introduction he pointed out differences between diagnostic and therapeutic antibodies. Whereas diagnostic antibodies are comparatively cheap and usually free of any patents, therapeutic antibodies are quite expensive and, in most cases, patent-protected. Following this, he gave us some general information concerning the principles of operation and application of therapeutic antibodies, e.g. that therapeutic effects are generated in the Fc-Region of the antibody. As an example of use, he taught us the antibody-labeling of tumor cells. This targeting of tumor antigens may lead to cross-links between antigens followed by apoptosis of tumor cells. Other consequences might be the attraction of macrophages und native killer cells and the creation of contact points for the complement system which is part of our immune system.
<P>The accurate effectiveness of an antibody depends on its glycosylation pattern whereupon the core region may appear similar to:
</P><DIV style="float:right;width:55%;">
M: D-Mannose
N: N-Acetyl-D-glucosamine
[Fuc]:Fucose
</DIV><P>
As a general problem regarding the antibody production in non-mammals like plants and especially microalgae Mr Hermentin advised us of different glycosyltransferases used in this species that create glycosylation patterns that are not biocompatible to humans.
To accomplish his lecture, he presented a possibility to avoid this problem in our organism <I>Phaeodactylum tricornutum</I>. Interestingly, PHAECTORY provides all enzymes required for 
N-Glycan biosynthesis in its ER and Golgi complex. Additionally, <I>P. tricornutum</I> is capable to build high-mannose structures. Unfortunately, the organism uses two glycosyltransferases, α(1,3)-Fucosyltransferase and β(1,2)-Xyloysltransferase, that are not compatible to humans. This means that the production of therapeutic antibodies in <I>P. tricornutum</I> for human application demands the knockout of these two genes.
</P><P>For further information check out these two articles:
</P><P>[1]	Baiet B, Burel C, Saint-Jean B, Louvet R, Menu-Bouaouiche L, Kiefer-Meyer MC, et al. N-glycans of <I>Phaeodactylum tricornutum</I> diatom and functional characterization of its N-acetylglucosaminyltransferase I enzyme. J Biol Chem. 2011, 286(8), 6152-64.
</P><P>[2]	Bowler C, Allen AE, Badger JH, Grimwood J, Jabbari K, Kuo A, et al. The Phaeodactylum genome reveals the evolutionary history of diatom genomes. Nature. 2008, 456(7219), 239-44.
		</P></DIV></DIV></DIV><DIV id="mr-footer-box"><DIV id="mr-footer"><DIV id="mr-footer-wrapper"><DIV id="mr-footer-links"><UL class="ul1"><LI><A href="https://2013.igem.org/Special:RecentChanges">Recent Changes</A></LI><LI><A href="https://2013.igem.org/Special:WhatLinksHere/Team:Marburg">What links here</A></LI><LI><A href="https://2013.igem.org/Special:SpecialPages">Special pages</A></LI><LI><A href="https://2013.igem.org/Special:Preferences">My preferences</A></LI></UL><UL class="ul2"><LI><A href="?printable=yes">Printable version</A></LI><LI><A href="https://2013.igem.org/2013.igem.org:Privacy_policy">Privacy policy</A></LI><LI><A href="https://2013.igem.org/2013.igem.org:General_disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2013.igem.org/Team:Marburg/Human_Practice/Talk_of_Peter_Hermentin">http://2013.igem.org/Team:Marburg/Human_Practice/Talk_of_Peter_Hermentin</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Marburg/Human_Practice/Talk_of_Peter_Hermentin" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Marburg/Human_Practice/Talk_of_Peter_Hermentin" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Marburg/Human_Practice/Talk_of_Peter_Hermentin&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Marburg/Human_Practice/Talk_of_Peter_Hermentin&amp;oldid=336376" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2013.igem.org:Privacy_policy" title="2013.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2013.igem.org:General_disclaimer" title="2013.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>